LLY vs OMCL · P/E 39, rev $22.97B vs P/E 90, rev $622.1M
Eli Lilly and Company (LLY) versus Omnicell Inc (OMCL) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Omnicell Inc (OMCL) is a health information services company listed on NASDAQ.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported OMCL revenue for 2026-06-30 was $622.1M. Net income was $35.6M. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. OMCL currently screens at market cap $1.80B and trailing P/E 89.9.
Not investment advice. Open the LLY and OMCL stock pages for the full models.
Not investment advice.